Daniel Lozano on eBV 2.0: Moving Beyond the Checkbox

Daniel Lozano on eBV 2.0: Moving Beyond the Checkbox

September 17, 2026

Chase Carpenter
Chase Carpenter VP, Marketing
GTN Insights
Get GTN Insights by Email
GTN Leakage Is Overwhelming Pharma Leaders—and It Shouldn’t Be
GTN Leakage Is Overwhelming Pharma Leaders—and It Shouldn’t Be

November 18, 2025

Gerard Rivera
Gerard Rivera Co-founder & CEO
PBM / Payer-based Leakage
Affordability Programs Aren’t Optional. They’re Life-Saving.
Affordability Programs Aren’t Optional. They’re Life-Saving.

October 30, 2025

Gerard Rivera
Gerard Rivera Co-founder & CEO
PBM / Payer-based Leakage
From Copay Blind Spots to $1B Saved: Why We Built RIS Rx
From Copay Blind Spots to $1B Saved: Why We Built RIS Rx

October 24, 2025

Gerard Rivera
Gerard Rivera Co-founder & CEO
Our Story
Welcoming John Driscoll as Chairman of our Board of Directors
Welcoming John Driscoll as Chairman of our Board of Directors

October 15, 2025

Gerard Rivera
Gerard Rivera Co-founder & CEO
Our PeoplePress Releases
The $90B Problem No One Sees at the Pharmacy Counter
The $90B Problem No One Sees at the Pharmacy Counter

September 15, 2025

Gerard Rivera
Gerard Rivera Co-founder & CEO
PBM / Payer-based Leakage

Learn why the world‘s top pharmaceutical companies trust RIS Rx to protect their patients and improve GTN.